What is Viltolarsen: Uses, Dosage, Side Effects and More

Viltolarsen is a prescription medication specifically designed to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation amenable to exon 53 skipping. This specialized medicine works by helping muscle cells produce a modified version of the dystrophin protein, which is essential for healthy muscle function.

If you or a loved one has been diagnosed with this specific type of DMD, viltolarsen represents a targeted treatment approach that can help slow the progression of muscle weakness. The medication is given through an intravenous infusion, meaning it's delivered directly into your bloodstream through a vein.

What is Viltolarsen?

Viltolarsen is an antisense oligonucleotide medication that belongs to a newer class of precision medicines. Think of it as a molecular messenger that gives specific instructions to your muscle cells about how to make protein.

The medication specifically targets patients with Duchenne muscular dystrophy who have genetic mutations that can benefit from exon 53 skipping. This genetic approach means the medicine is designed to work only for people with certain DNA changes in their dystrophin gene.

Viltolarsen received FDA approval in 2020, making it one of the more recent additions to DMD treatment options. The drug works at the genetic level to help restore some dystrophin protein production in muscle cells.

What is Viltolarsen Used For?

Viltolarsen is used exclusively to treat Duchenne muscular dystrophy in patients whose genetic testing confirms they have a dystrophin gene mutation amenable to exon 53 skipping. This represents about 8% of all DMD patients.

DMD is a serious genetic condition that causes progressive muscle weakness and degeneration. Boys with this condition typically begin showing symptoms in early childhood, with muscle weakness starting in the legs and pelvis before spreading to other muscle groups.

The medication aims to slow the progression of muscle weakness and help maintain muscle function for as long as possible. While it's not a cure, viltolarsen can help preserve mobility and independence in eligible patients.

How Does Viltolarsen Work?

Viltolarsen works by targeting the genetic instructions that tell muscle cells how to make dystrophin protein. In DMD, genetic mutations prevent cells from making functional dystrophin, which muscles need to stay healthy and strong.

The medication uses a technique called exon skipping to help cells bypass the problematic genetic section. By skipping over exon 53, muscle cells can produce a shortened but partially functional version of dystrophin protein.

This approach is considered a moderately targeted therapy rather than a strong or weak medication in the traditional sense. Its effectiveness depends entirely on having the right genetic mutation, making genetic testing essential before starting treatment.

How Should I Take Viltolarsen?

Viltolarsen is given as an intravenous infusion, which means it's delivered directly into your bloodstream through a vein. The infusion typically takes about 60 minutes and is administered once weekly at a healthcare facility.

You don't need to fast before your infusion, and you can eat normally on treatment days. Some patients find it helpful to stay well-hydrated by drinking plenty of water before and after their infusion.

Your healthcare team will monitor you during each infusion for any signs of allergic reactions or other side effects. The dose is carefully calculated based on your body weight, typically 80 mg per kilogram.

Plan to spend about 2-3 hours at the healthcare facility for each treatment, including preparation time, the actual infusion, and post-treatment monitoring. Most patients develop a routine around their weekly appointments.

How Long Should I Take Viltolarsen For?

Viltolarsen is typically a long-term treatment that you'll continue for as long as it's providing benefit and is well-tolerated. There's no predetermined end date for this medication.

Your doctor will regularly assess how well the treatment is working by monitoring your muscle function, strength tests, and overall mobility. These evaluations help determine whether continuing treatment is beneficial.

Some patients may need to take breaks from treatment if they experience side effects or if their medical situation changes. Your healthcare team will work with you to develop the best long-term treatment plan for your specific needs.

What Are the Side Effects of Viltolarsen?

Like all medications, viltolarsen can cause side effects, though many people tolerate it well. The most common side effects are generally mild and manageable with proper medical supervision.

Here are the side effects you might experience, organized from most common to less frequent:

Common side effects that many patients experience:

• Upper respiratory tract infections (cold-like symptoms)
• Injection site reactions (redness, swelling, or discomfort where the IV was placed)
• Cough
• Fever
• Headache

Less common but notable side effects:

• Kidney function changes (detected through blood tests)
• Allergic reactions during infusion
• Nausea or stomach discomfort
• Fatigue or tiredness
• Dizziness

Rare but serious side effects that require immediate medical attention:

• Severe allergic reactions (difficulty breathing, swelling of face or throat)
• Significant kidney problems (changes in urination, swelling in legs or feet)
• Severe infusion reactions (chest pain, severe dizziness, rapid heartbeat)

Most side effects are mild and temporary, but it's important to report any concerns to your healthcare team. They can adjust your treatment plan or provide supportive care to help manage any discomfort.

Who Should Not Take Viltolarsen?

Viltolarsen is not suitable for everyone, and certain medical conditions or circumstances may make this treatment inappropriate for you. Your doctor will carefully evaluate your medical history before recommending this medication.

You should not take viltolarsen if you have a known allergy to the medication or any of its components. Additionally, patients without the specific genetic mutation amenable to exon 53 skipping will not benefit from this treatment.

Here are the main reasons why viltolarsen might not be right for you:

Absolute contraindications (you should not take viltolarsen):

• No confirmed genetic mutation amenable to exon 53 skipping
• Known severe allergic reaction to viltolarsen
• Severe kidney disease that would make monitoring difficult

Conditions requiring extra caution and monitoring:

• Existing kidney problems (even mild ones)
• History of severe allergic reactions to other medications
• Active infections or compromised immune system
• Pregnancy or breastfeeding (safety not established)
• Other heart or lung conditions that might complicate treatment

Your healthcare team will work with you to determine if viltolarsen is the right choice based on your individual medical situation and the potential benefits versus risks.

Viltolarsen Brand Name

Viltolarsen is marketed under the brand name Viltepso. This is the name you'll see on prescription labels and medical documentation.

Viltepso is manufactured by NS Pharma and is the only commercially available form of viltolarsen. There are currently no generic versions of this medication available.

When discussing your treatment with healthcare providers or insurance companies, you may hear both names used interchangeably. Both refer to the same medication.

Viltolarsen Alternatives

Several other medications are available for treating Duchenne muscular dystrophy, though the best choice depends on your specific genetic mutation and individual circumstances. Each alternative works differently and targets different genetic changes.

Other exon-skipping medications include eteplirsen (Exondys 51) for patients amenable to exon 51 skipping, and golodirsen (Vyondys 53) for exon 53 skipping. Casimersen (Amondys 45) targets exon 45 skipping.

Non-exon-skipping alternatives include ataluren (Translarna) for patients with nonsense mutations, and deflazacort or prednisone, which are corticosteroids that can help slow muscle deterioration. Gene therapy with microdystrophin (Elevidys) is also available for certain age groups.

Your doctor will consider your specific genetic mutation, age, current symptoms, and overall health when recommending the most appropriate treatment option for your situation.

Is Viltolarsen Better Than Golodirsen?

Both viltolarsen and golodirsen are designed to treat the same genetic subset of DMD patients through exon 53 skipping, but they have some important differences that might make one more suitable for you than the other.

Viltolarsen is given weekly as a 60-minute infusion, while golodirsen requires weekly 35-60 minute infusions. Both medications have shown the ability to increase dystrophin production in muscle cells, though the clinical significance of these changes is still being studied.

The choice between these medications often depends on factors like your response to treatment, side effect profile, insurance coverage, and your healthcare team's experience with each medication. Some patients may try one and later switch to the other based on their individual response.

Your doctor will consider your specific medical history, lifestyle factors, and treatment goals when helping you decide which medication might be the better choice for your situation.